Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492463 · ClinicalTrials.gov registry record · Phase 2
The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 94
- Enrollment target
NCT03492463 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 94 participants.
The verdict
NCT03492463, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 94 participants
- Enrollment target
Study Summary
This study plans to investigate whether using electronic cigarettes (e-cigarettes) or skin patches containing nicotine affects switching from smoking conventional combustible (burning) cigarettes.
Interventions
- DRUG Nicotine patch
- OTHER E-cigarettes
- OTHER Placebo patch
- OTHER Non-nicotine e-cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2018-08-06 |
| Est. Completion | 2021-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03492463
The ClinicalTrials.gov registry entry for NCT03492463 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nicotine patch is the first listed.
NCT03492463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03492463 about?
NCT03492463 is a clinical study titled "The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products". This study plans to investigate whether using electronic cigarettes (e-cigarettes) or skin patches containing nicotine affects switching from smoking conventional combustible (burning) cigarettes.
What is the current status of trial NCT03492463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 94 participants. The study started on 2018-08-06. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03492463?
The interventions under investigation include: Nicotine patch (DRUG), E-cigarettes (OTHER), Placebo patch (OTHER), Non-nicotine e-cigarettes (OTHER).
Who is sponsoring clinical trial NCT03492463?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.